Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance. [PDF]
Prasher P, Sharma M.
europepmc +1 more source
Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation. [PDF]
Solomon C +11 more
europepmc +1 more source
Discovery of Cilnidipine Cocrystals with Enhanced Dissolution by the Use of Computational Tools and Semiautomatic High-Throughput Screening. [PDF]
Guidetti M +5 more
europepmc +1 more source
Deep Supramolecular Language Processing for Co-Crystal Prediction. [PDF]
Birolo R +5 more
europepmc +1 more source
Formulation Strategies to Enhance the Solubility of Poorly Water-Soluble Drugs and Phytochemicals: Current Advances and Challenges. [PDF]
Jacob S, Shah H, Nair AB.
europepmc +1 more source
First Crystal Structure of an Aspartame Cocrystal. [PDF]
Fereidouni N, Aljohani M, Erxleben A.
europepmc +1 more source
Strategic Modulation of Isoniazid Solubility through Cocrystal Formation for Long-Acting Microneedle Therapy of Tuberculosis. [PDF]
Fandiño OE +4 more
europepmc +1 more source
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement. [PDF]
Screen MA +7 more
europepmc +1 more source
An Optimization Approach for the Production of High-Purity Vitamin C‑Nicotinamide Cocrystals by the Gas Antisolvent (GAS) Technique with CO<sub>2</sub> and Ethanol. [PDF]
Balbinot Filho CA +8 more
europepmc +1 more source
Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. [PDF]
Frösler HM +5 more
europepmc +1 more source

